investorscraft@gmail.com

Intrinsic value of USANA Health Sciences, Inc. (USNA)

Previous Close$69.47
Intrinsic Value
Upside potential
Previous Close
$69.47

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh118.31 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %4.5NaN
Revenue, $1186NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1016NaN
Operating income, $m170NaN
EBITDA, $m192NaN
Interest expense (income), $mNaN
Earnings before tax, $m171NaN
Tax expense, $m54NaN
Net income, $m117NaN

BALANCE SHEET

Cash and short-term investments, $m240NaN
Total assets, $m578NaN
Adjusted assets (=assets-cash), $m338NaN
Average production assets, $m175NaN
Working capital, $m202NaN
Total debt, $m17NaN
Total liabilities, $m183NaN
Total equity, $m395NaN
Debt-to-equity ratio0.044NaN
Adjusted equity ratio0.481NaN

CASH FLOW

Net income, $m117NaN
Depreciation, amort., depletion, $m22NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m121NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-13NaN
Free cash flow, $m134NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m202
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount